DK0994890T3 - Benzimidazolderivater - Google Patents

Benzimidazolderivater

Info

Publication number
DK0994890T3
DK0994890T3 DK98936306T DK98936306T DK0994890T3 DK 0994890 T3 DK0994890 T3 DK 0994890T3 DK 98936306 T DK98936306 T DK 98936306T DK 98936306 T DK98936306 T DK 98936306T DK 0994890 T3 DK0994890 T3 DK 0994890T3
Authority
DK
Denmark
Prior art keywords
benzimidazole
Prior art date
Application number
DK98936306T
Other languages
Danish (da)
English (en)
Inventor
John Charles Drach
Leroy B Townsend
Frank Leslie Boyd Jr
Stanley Dawes Chamberlain
Susan Mary Daluge
David Norman Deaton
Marc W Andersen
George Andrew Freeman
Original Assignee
Univ Michigan
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9711982.0A external-priority patent/GB9711982D0/en
Priority claimed from GBGB9714552.8A external-priority patent/GB9714552D0/en
Application filed by Univ Michigan, Glaxo Group Ltd filed Critical Univ Michigan
Application granted granted Critical
Publication of DK0994890T3 publication Critical patent/DK0994890T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98936306T 1997-06-10 1998-06-08 Benzimidazolderivater DK0994890T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711982.0A GB9711982D0 (en) 1997-06-10 1997-06-10 Benzimidazole derivatives
GBGB9714552.8A GB9714552D0 (en) 1997-07-11 1997-07-11 Benzimidazole derivatives
PCT/EP1998/003380 WO1998056761A2 (fr) 1997-06-10 1998-06-08 Derives de benzimidazole

Publications (1)

Publication Number Publication Date
DK0994890T3 true DK0994890T3 (da) 2003-12-01

Family

ID=26311687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98936306T DK0994890T3 (da) 1997-06-10 1998-06-08 Benzimidazolderivater

Country Status (35)

Country Link
US (1) US6455507B1 (fr)
EP (1) EP0994890B1 (fr)
JP (1) JP4548866B2 (fr)
KR (1) KR20010020465A (fr)
CN (1) CN1265665A (fr)
AP (1) AP1262A (fr)
AR (1) AR012964A1 (fr)
AT (1) ATE246700T1 (fr)
AU (1) AU740792C (fr)
BR (1) BR9810745A (fr)
CA (1) CA2293470C (fr)
CO (1) CO4970737A1 (fr)
DE (1) DE69816992T2 (fr)
DK (1) DK0994890T3 (fr)
EA (1) EA002305B1 (fr)
EE (1) EE9900564A (fr)
ES (1) ES2205527T3 (fr)
HK (1) HK1024921A1 (fr)
HR (1) HRP980303B1 (fr)
HU (1) HUP0002224A3 (fr)
ID (1) ID24054A (fr)
IL (1) IL133285A0 (fr)
IS (1) IS5285A (fr)
MA (1) MA26504A1 (fr)
MY (1) MY132872A (fr)
NO (1) NO314847B1 (fr)
NZ (1) NZ501415A (fr)
OA (1) OA11230A (fr)
PE (1) PE84099A1 (fr)
PL (1) PL337773A1 (fr)
PT (1) PT994890E (fr)
SK (1) SK171499A3 (fr)
TR (1) TR199903053T2 (fr)
TW (1) TW565566B (fr)
WO (1) WO1998056761A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199801431T2 (xx) 1996-01-23 1998-10-21 The Regents Of The University Of Michigan Antiviral aktif maddeler olarak de�i�tirilmi� benzimidazol n�kleosidler.
PL338454A1 (en) 1997-07-30 2000-11-06 Univ Michigan Lixofuranosilbenzimidazoles as antiviral agents
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
ATE369853T1 (de) 2001-03-12 2007-09-15 Avanir Pharmaceuticals Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
EA011515B1 (ru) * 2003-08-01 2009-04-28 Янссен Фармацевтика Н.В. Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
WO2005049582A1 (fr) * 2003-11-14 2005-06-02 Auspex Pharmaceuticals, Inc. Procede pour preparer de nouveaux analogues de nucleoside, et leurs utilisations
MX2007010272A (es) * 2005-02-22 2008-03-12 Univ Michigan Inhibidores de moleculas pequenas de mdm2 y usos de los mismos.
DE102005019549A1 (de) * 2005-04-25 2006-12-14 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol
US7989422B2 (en) * 2005-12-22 2011-08-02 Alchemia Limited Antibacterial agents
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
US7951845B2 (en) 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
US8338397B2 (en) 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
WO2009023855A2 (fr) * 2007-08-15 2009-02-19 Isis Pharmaceuticals, Inc. Analogues d'acide nucléique de tétrahydropyrane
WO2009100045A1 (fr) * 2008-02-04 2009-08-13 Translational Genomics Research Institute Composés, compositions pharmaceutiques et procédés d’utilisation de dérivés d’acide hydroxamique
WO2009100320A2 (fr) 2008-02-07 2009-08-13 Isis Pharmaceuticals, Inc. Analogues d’acides nucléiques de cyclohexitol bicycliques
WO2010036613A1 (fr) 2008-09-26 2010-04-01 Merck Sharp & Dohme Corp. Nouveaux dérivés de benzimidazole cycliques utiles en tant qu'agents anti-diabétiques
CA2741125A1 (fr) 2008-10-22 2010-04-29 Merck Sharp & Dohme Corp. Nouveaux derives de benzimidazole cycliques utiles comme agents anti-diabetiques
WO2010051176A1 (fr) 2008-10-29 2010-05-06 Merck Sharp & Dohme Corp. Nouveaux agents antidiabétiques utiles avec des dérivés de benzimidazole cycliques
CN102271509A (zh) 2008-10-31 2011-12-07 默沙东公司 用于抗糖尿病药的新型环苯并咪唑衍生物
WO2010091308A2 (fr) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Composés oligomères et procédés connexes
WO2010090969A1 (fr) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Analogues d'acide nucléique de tétrahydropyrane
US8895596B2 (en) 2010-02-25 2014-11-25 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
CN103154014B (zh) 2010-04-28 2015-03-25 Isis制药公司 修饰核苷、其类似物以及由它们制备的寡聚化合物
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
WO2014134493A1 (fr) * 2013-03-01 2014-09-04 Los Alamos National Security, Llc Composés antibiotiques à large spectre et utilisation de ceux-ci
EP3137476B1 (fr) 2014-04-28 2019-10-09 Ionis Pharmaceuticals, Inc. Composés oligomères modifiés par liaison
US10077242B2 (en) * 2014-12-01 2018-09-18 Virginia Commonwealth University Convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
KR102583547B1 (ko) 2020-03-30 2023-10-06 (주)바이오메트릭스 테크놀로지 신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도
EP3907230B1 (fr) 2020-03-30 2024-08-28 Biometrix Technology Inc. Nouveaux dérivés de benzimidazole, leur procédé de préparation et leur utilisation comme agent anticancéreux
KR102449266B1 (ko) 2020-06-23 2022-09-30 (주)바이오메트릭스 테크놀로지 항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법
US12043644B2 (en) 2020-06-23 2024-07-23 Biometrix Technology Inc Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same
KR102342313B1 (ko) 2021-08-27 2021-12-24 (주)바이오메트릭스 테크놀로지 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1491244A (fr) 1966-03-09 1967-08-11 Nouveaux benzimidazoles solubles
FR1476350A (fr) 1966-04-18 1967-04-07 Yale & Towne G M B H Ferme-porte automatique à frein
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
ES8101067A1 (es) 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
EP0304624A3 (fr) 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Composés de benzimidazol-2-yl-pyridinium
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
EP0521463A3 (en) 1991-07-04 1993-04-14 Hoechst Aktiengesellschaft Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (fr) 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Benzimidazoles polysubstitues utilises comme agents antiviraux
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
ES2205527T3 (es) 2004-05-01
HK1024921A1 (en) 2000-10-27
NO996086L (no) 2000-02-09
PE84099A1 (es) 1999-09-24
HRP980303A2 (en) 1999-04-30
EP0994890B1 (fr) 2003-08-06
WO1998056761A2 (fr) 1998-12-17
SK171499A3 (en) 2000-08-14
PT994890E (pt) 2003-11-28
CA2293470A1 (fr) 1998-12-17
HUP0002224A1 (hu) 2001-04-28
JP2002504105A (ja) 2002-02-05
PL337773A1 (en) 2000-09-11
DE69816992T2 (de) 2004-07-22
NO996086D0 (no) 1999-12-09
AU740792C (en) 2003-01-23
AP1262A (en) 2004-03-16
OA11230A (en) 2003-07-09
EE9900564A (et) 2000-06-15
HUP0002224A3 (en) 2003-05-28
NZ501415A (en) 2001-10-26
KR20010020465A (ko) 2001-03-15
BR9810745A (pt) 2001-03-13
TR199903053T2 (xx) 2000-11-21
CA2293470C (fr) 2008-05-13
EA199901031A1 (ru) 2000-06-26
JP4548866B2 (ja) 2010-09-22
AU740792B2 (en) 2001-11-15
EA002305B1 (ru) 2002-02-28
AU8536098A (en) 1998-12-30
IS5285A (is) 1999-12-06
EP0994890A2 (fr) 2000-04-26
ID24054A (id) 2000-07-06
US20020094963A1 (en) 2002-07-18
IL133285A0 (en) 2001-04-30
US6455507B1 (en) 2002-09-24
HRP980303B1 (en) 2002-08-31
AR012964A1 (es) 2000-11-22
TW565566B (en) 2003-12-11
MA26504A1 (fr) 2004-12-20
CO4970737A1 (es) 2000-11-07
MY132872A (en) 2007-10-31
DE69816992D1 (en) 2003-09-11
CN1265665A (zh) 2000-09-06
WO1998056761A3 (fr) 1999-04-15
NO314847B1 (no) 2003-06-02
AP9901707A0 (en) 1999-12-31
ATE246700T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
DK0994890T3 (da) Benzimidazolderivater
ATA93198A (de) Fluoxetinpellets
DE69825643D1 (de) Gehrungssägeschwenklagerfestspannvorrichtung
DE69832435D1 (de) Fahrzeugsitzverstellschienen
DE59813776D1 (de) Kraftsoffversorgungsanlage
DE69840931D1 (de) Ergiesensorrückopplung
DE69816767D1 (de) Polklemme
DE69822175D1 (de) Reibe
DE69840529D1 (de) Packerkultivator
DE69829497D1 (de) Wickeldetektiervorrichtung
FI972255A0 (fi) Vaextunderlag
DE69823379D1 (de) Kraftstoffffilter
DE69805902D1 (de) Einbindevorrichtung
DE59804377D1 (de) Kryoventil
DE69732087D1 (de) Taktsignalzuführvorrichtung
FI970496A0 (fi) Sidobegraensare
DE59806025D1 (de) Normalsäschar
FI972138A0 (fi) Returtraog i bestrykningsanordning
DE59800820D1 (de) Stiellose kniegelenkendoprothese
FI974354A0 (fi) Kvaevereducering i avloppsvatten
FI974635A0 (fi) I vaermebatteri integrerbar ventilkonstruktion
FI971698A0 (fi) Klingstyrenhet i en cirkelsaog
FI971123A0 (fi) Foervarings- och transportredskap i synnerhet foer pappersprodukter
FI974373A0 (fi) Avgasutlopp i utombordsmotorer
FI971651A0 (fi) Spaormaskin i en elmaskin